A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention: Results of the evaluating enoxaparin clotting times (ELECT) study.
Clinical Pharmacology and Therapeutics.
Times cited: 42
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT study.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 54